An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA

Joseph A. TyndallDivision of Infections Disease, Department of Emergency Medicine, The University of Florida College of Medicine, Gainesville, FL, USA, Correspondence[email protected]

Roy GeronaDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA,

Giuliano De PortuDivision of Infections Disease, Department of Emergency Medicine, The University of Florida College of Medicine, Gainesville, FL, USA,

Jordan TreckiOffice of Diversion Control/Drug and Chemical Evaluation Section, Drug Enforcement Administration, Springfield, VA, USA,

Marie-Carmelle ElieDivision of Infections Disease, Department of Emergency Medicine, The University of Florida College of Medicine, Gainesville, FL, USA,

Judith LucasDivision of Infections Disease, Department of Emergency Medicine, The University of Florida College of Medicine, Gainesville, FL, USA,

John SlishDivision of Infections Disease, Department of Emergency Medicine, The University of Florida College of Medicine, Gainesville, FL, USA,

Kenneth RandDivision of Infections Disease, Department of Pathology, Immunology and Laboratory Medicine, The University of Florida College of Medicine, Gainesville, FL, USA,

Lindsay BazydloDivision of Infections Disease, Department of Emergency Medicine, The University of Florida College of Medicine, Gainesville, FL, USA, ;Division of Laboratory Medicine, Department of Pathology, The University of Virginia, Charlottesville, VA, USA,

Martina HolderUF Health Shands, Gainesville, FL, USA,

Matthew F. RyanDivision of Infections Disease, Department of Emergency Medicine, The University of Florida College of Medicine, Gainesville, FL, USA,

Paul MyersFlorida Department of Health, Alachua County, Gainesville, FL, USA,

Nicole IovineDepartment of Medicine, The University of Florida College of Medicine, Gainesville, FL, USA,

Michelle PlourdeUF Health Shands, Gainesville, FL, USA,

Emily WeeksDivision of Infections Disease, Department of Emergency Medicine, The University of Florida College of Medicine, Gainesville, FL, USA,

James R. HanleyOchsner Clinic Foundation Hospital, New Orleans, LA, USA,

Greg EndresCayman Chemical, Ann Arbor, MI, USA, and

Danielle St. GermaineCayman Chemical, Ann Arbor, MI, USA, and

Paul J. DobrowolskiCayman Chemical, Ann Arbor, MI, USA, and

Michael SchwartzNational Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA

show all

An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA

Articles from other publishers (51)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA

Citations (57)

Read on this site (6)

Articles from other publishers (51)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date